A summary of presentations from the weekly Summit partner webinars
September 10, 2026
VIP: 2026–27 Respiratory Season Evidence Review Summary – Angela Ulrich, PhD, MPH, Director of Research and Assistant Professor, Center for Infectious Disease Research and Policy, University of Minnesota, VIP
Angela Ulrich, PhD, MPH, presented key findings of VIP’s review of the evidence for the safety and effectiveness of the influenza, COVID-19, and respiratory syncytial virus (RSV) vaccines.
AAFP: 2026–27 Respiratory Season Vaccine Recommendations – Margot Savoy, MD, MPH, FAAFP, Chief Medical Officer, AAFP
Margot Savoy, MD, MPH, FAAFP, described AAFP’s guidance development process and their recommendations for nonpregnant, immunocompetent adults and health care professionals.
AAP: 2026–27 Respiratory Season Immunization Recommendations – Sunnah Kim, MS, RN, Senior Director, Pediatric Practice and Health Care Delivery, AAP
Sunnah Kim, MS, RN, outlined updates to AAP’s process for developing recommendations and its vaccine recommendations for those 18 and younger.
ACOG: 2026–27 Respiratory Season Vaccination Recommendations – Kim Fortner, MD, Professor; Program Director, Maternal Fetal Medicine Fellowship; Director, Division of Maternal-Fetal Medicine; Vice Chair, Obstetric Operations and Quality, Division of Maternal-Fetal Medicine, University of Tennessee Medical Center; ACOG
Kim Fortner, MD, summarized ACOG’s recommendations and rationale for immunization among those who are pregnant, were recently pregnant, are considering pregnancy, or are lactating.
IDSA: Updating IDSA’s Vaccine Guidelines – Jon Heald, MA, Senior Director of Clinical Policy, IDSA
Jon Heald, MA, presented the process IDSA used to develop guidelines and its recommendations for vaccines for immunocompromised children and adults.